IBDEI3AS ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4)
 ;;=^IBE(358.4,
 ;;^UTILITY(U,$J,358.4,0)
 ;;=IMP/EXP SELECTION GROUP^358.4I^2545^2545
 ;;^UTILITY(U,$J,358.4,1,0)
 ;;=ADMINISTRATIVE PURPOSES^1^1
 ;;^UTILITY(U,$J,358.4,2,0)
 ;;=FAMILY CIRCUMSTANCES^2^1
 ;;^UTILITY(U,$J,358.4,3,0)
 ;;=HOUSING & ECONOMIC CIRCUM^3^1
 ;;^UTILITY(U,$J,358.4,4,0)
 ;;=MENTAL & BEHAVIORAL PROBLEMS^4^1
 ;;^UTILITY(U,$J,358.4,5,0)
 ;;=PERSONS SEEKING CONSULT^5^1
 ;;^UTILITY(U,$J,358.4,6,0)
 ;;=SCREENING FOR MENTAL/DEVELOPMENT^6^1
 ;;^UTILITY(U,$J,358.4,7,0)
 ;;=TEAM CONFERENCE^3^2
 ;;^UTILITY(U,$J,358.4,8,0)
 ;;=SOCIAL WORKER^2^2
 ;;^UTILITY(U,$J,358.4,9,0)
 ;;=PSYCH^1^2
 ;;^UTILITY(U,$J,358.4,10,0)
 ;;=MD/PA/NP-ESTAB PATIENT^1^3
 ;;^UTILITY(U,$J,358.4,11,0)
 ;;=MD/PA/NP-NEW PATIENT^2^3
 ;;^UTILITY(U,$J,358.4,12,0)
 ;;=NEW PATIENT^3^4
 ;;^UTILITY(U,$J,358.4,13,0)
 ;;=ESTABLISHED PATIENT^1^4
 ;;^UTILITY(U,$J,358.4,14,0)
 ;;=CONSULTATION^2^4
 ;;^UTILITY(U,$J,358.4,15,0)
 ;;=FUNCTIONAL BRAIN MAPPING^2^5
 ;;^UTILITY(U,$J,358.4,16,0)
 ;;=CNS ASSESSMENTS/TESTS^1^5
 ;;^UTILITY(U,$J,358.4,17,0)
 ;;=ALCOHOL INDUCED MENTAL DISORDERS^1^6
 ;;^UTILITY(U,$J,358.4,18,0)
 ;;=DEMENTIAS^3^6
 ;;^UTILITY(U,$J,358.4,19,0)
 ;;=DRUG INDUCED MENTAL DISORDERS^3^6
 ;;^UTILITY(U,$J,358.4,20,0)
 ;;=OTHER MENTAL/NEURO DISORDERS^4^6
 ;;^UTILITY(U,$J,358.4,21,0)
 ;;=PERSISTENT MENTAL DISODERS^5^6
 ;;^UTILITY(U,$J,358.4,22,0)
 ;;=TRANSIENT MENTAL DISORDERS^7^6
 ;;^UTILITY(U,$J,358.4,23,0)
 ;;=CEREBROVASCULAR DISEASES^2^6
 ;;^UTILITY(U,$J,358.4,24,0)
 ;;=SUICIDE IDEATIONS/ATTEMPTS^6^6
 ;;^UTILITY(U,$J,358.4,25,0)
 ;;=EEG LTM^1^7
 ;;^UTILITY(U,$J,358.4,26,0)
 ;;=EEG PROCEDURAL^3^7
 ;;^UTILITY(U,$J,358.4,27,0)
 ;;=EEG ROUTINE^4^7
 ;;^UTILITY(U,$J,358.4,28,0)
 ;;=INTRAOPERATIVE EVOKED POTENTIALS^5^7
 ;;^UTILITY(U,$J,358.4,29,0)
 ;;=NEUROLOGY/SEIZURE/VNS PROGRAMMING^6^7
 ;;^UTILITY(U,$J,358.4,30,0)
 ;;=EEG MONITORING^2^7
 ;;^UTILITY(U,$J,358.4,31,0)
 ;;=SEIZURES/EPILEPSY/SPELLS^1^8
 ;;^UTILITY(U,$J,358.4,32,0)
 ;;=CEREBROVASCULAR DISEASE^2^8
 ;;^UTILITY(U,$J,358.4,33,0)
 ;;=DIZZINESS^3^8
 ;;^UTILITY(U,$J,358.4,34,0)
 ;;=ENCEPHALOPATHY^4^8
 ;;^UTILITY(U,$J,358.4,35,0)
 ;;=HEADACHE^5^8
 ;;^UTILITY(U,$J,358.4,36,0)
 ;;=MOVEMENT DISORDERS^6^8
 ;;^UTILITY(U,$J,358.4,37,0)
 ;;=NEOPLASMS^7^8
 ;;^UTILITY(U,$J,358.4,38,0)
 ;;=NEURODEGENERATIVE DISEASE^8^8
 ;;^UTILITY(U,$J,358.4,39,0)
 ;;=SLEEP DISORDERS^9^8
 ;;^UTILITY(U,$J,358.4,40,0)
 ;;=SPECIAL SCREENING^10^8
 ;;^UTILITY(U,$J,358.4,41,0)
 ;;=OTHER^11^8
 ;;^UTILITY(U,$J,358.4,42,0)
 ;;=EDUCATION^2^9
 ;;^UTILITY(U,$J,358.4,43,0)
 ;;=MEDICAL NUTRITION THERAPY^3^9
 ;;^UTILITY(U,$J,358.4,44,0)
 ;;=TEAM CONFERENCE^7^9
 ;;^UTILITY(U,$J,358.4,45,0)
 ;;=ASSESSMENT^1^9
 ;;^UTILITY(U,$J,358.4,46,0)
 ;;=MEDICATION THERAPY MANAGEMENT^4^9
 ;;^UTILITY(U,$J,358.4,47,0)
 ;;=PHYSICAL THERAPY^5^9
 ;;^UTILITY(U,$J,358.4,48,0)
 ;;=PROLONGED CLINICAL STAFF SERVICES^6^9
 ;;^UTILITY(U,$J,358.4,49,0)
 ;;=NEW PATIENT^2^10
 ;;^UTILITY(U,$J,358.4,50,0)
 ;;=ESTABLISHED PATIENT^1^10
 ;;^UTILITY(U,$J,358.4,51,0)
 ;;=CONSULTATIONS^3^10
 ;;^UTILITY(U,$J,358.4,52,0)
 ;;=BODY MASS INDEX (BMI)^1^11
 ;;^UTILITY(U,$J,358.4,53,0)
 ;;=COUNSELING^2^11
 ;;^UTILITY(U,$J,358.4,54,0)
 ;;=DIABETES W/O COMPLICATION^3^11
 ;;^UTILITY(U,$J,358.4,55,0)
 ;;=OVERWEIGHT/OBESITY^4^11
 ;;^UTILITY(U,$J,358.4,56,0)
 ;;=SUICIDE IDEATIONS/ATTEMPTS^5^11
 ;;^UTILITY(U,$J,358.4,57,0)
 ;;=EDUCATION/TRAINING^1^12
 ;;^UTILITY(U,$J,358.4,58,0)
 ;;=PROCEDURE CODES-GROUP^4^12
